Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Pharmacol.

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1640365

Unveiling the therapeutic potential of caudatin: Structural optimization, pharmacological mechanisms, and therapeutic implications

Provisionally accepted
Guohui  ShiGuohui Shi1Linlin  NiLinlin Ni2Xiaoni  KongXiaoni Kong3Rutong  RenRutong Ren1Xinyu  ShiXinyu Shi4Yang  XuYang Xu4Zhizi  QuZhizi Qu4Honglei  ZhouHonglei Zhou4*Xiusheng  ZhangXiusheng Zhang1*
  • 1Shandong Xiehe University, Jinan, China
  • 2Shandong University of Traditional Chinese Medicine Second Affiliated Hospital, Jinan, China
  • 3Shandong College of Traditional Chinese Medicine, Yantai, China
  • 4Shandong University of Traditional Chinese Medicine, Jinan, China

The final, formatted version of the article will be published soon.

Caudatin is a C₂₁ steroidal glycoside isolated from many species of the genus Cynanchum, has been utilized by traditional medicine to treat cancer and inflammation which is increasingly being considered a drug candidate because of the pharmacological activity it displays. This review provides a discussion of caudatin's structure-activity relationship (SAR), pharmacology, and therapeutic uses along with a synthesis of future challenges. Caudatin is a potent anti-cancer therapeutic that has been shown to modulate several important signaling pathways, which include but are not limited to: Wnt/β-catenin, NF-κB, and PI3K/AKT pathway, induce apoptosis through ROS mediated mitochondrial dysfunction, reduce metastatic spread through inhibition of epithelial-mesenchymal transition (EMT), and have an anti-inflammatory effect through inhibition of JNK/AP-1/NF-κB signaling. Caudatin has also displayed neuroprotection in models of Alzheimer's disease by activating TFEB and the autophagosome-lysosomal pathway mechanism of action, while also modulating PPARα. Furthermore, pharmacokinetic studies indicate that caudatin is rapidly absorbed and is able to selectively tail hepatic tissue while having little to no toxicity or significant adverse events in preclinical animal studies. Structure-activity studies suggest that modifications on the C-3 hydroxyl position, primarily with nitrogen heterocycles and/or sugars greatly enhance the bioactivity and solubility. With caudatin being such a great scaffold for medicinal chemistry, there is great opportunity to take advantage of caudatin as a building block to generate novel therapies which bridge traditional medicine with modern drug discovery. The future is aimed primarily at a combination strategy of synthetic derivatives, translational studies, and formulations. in further exploring caudatin as a treatment for cancer and neurodegenerative diseases, and inflammation.

Keywords: Caudatin, structural optimization, pharmacological mechanisms, Therapeutic implications, molecular signaling

Received: 03 Jun 2025; Accepted: 22 Aug 2025.

Copyright: © 2025 Shi, Ni, Kong, Ren, Shi, Xu, Qu, Zhou and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Honglei Zhou, Shandong University of Traditional Chinese Medicine, Jinan, China
Xiusheng Zhang, Shandong Xiehe University, Jinan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.